{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:11:18Z","timestamp":1790428278046,"version":"4.1.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2556,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Our center has attempted to minimize corticosteroid (CS) use in all of our orthotopic liver transplantation (OLT) recipients. Because patients with autoimmune hepatitis (AIH) typically require CSs after transplantation, we reviewed our experience in this cohort of patients to determine (1) patient outcomes including recurrent disease and (2) long-term requirements for CS use in AIH patients. From 1988 to 2006, 1102 OLTs were performed in 1032 adult patients at the University of Colorado, of whom 66 (6%) with AIH received 68 allografts. Recurrence was defined by a clinically worsening examination and histological evidence from biopsy. Bivariate and multivariate analyses were used to evaluate predictors of CS withdrawal. Twelve potential predictors of CS discontinuation were considered: age, gender, presence of inflammatory bowel disease (IBD), type of graft (cadaver or living donor), recurrence of AIH, warm ischemia time, follow-up time (time since transplant), and immunosuppressants (cyclosporine, tacrolimus, sirolimus, azathioprine, and mycophenolate mofetil). Overall survival at 5 years was 91%. The 1- and 5-year recurrence-free survival was 88% and 59%, respectively. Risk (incidence) of recurrent AIH at 1, 3, and 5 years was 12%, 26%, and 36%, respectively. Disease recurred in 23 of 66 patients or 34.8%. Of the 23 patients who developed recurrent disease, none received a second transplant because of recurrent disease. CSs were withdrawn in 50% of patients at the time of review. Only 2 factors on multivariate analysis were strongly associated negatively with CS withdrawal: (1) an increasing dose of the immunosuppressant and (2) the presence of IBD. Controlling for these other factors, we found that recurrent disease did not strongly influence CS withdrawal. In conclusion, outcomes in AIH patients were quite favorable, and none of the patients required retransplantation for recurrent AIH. With a CS minimization approach, one-half of the patients were able to remain CS-free.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.21525","type":"journal-article","created":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T18:18:14Z","timestamp":1219947494000},"page":"1281-1286","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":96,"title":["Liver Transplantation for Autoimmune Hepatitis and the Success of Aggressive Corticosteroid Withdrawal"],"prefix":"10.1097","volume":"14","author":[{"given":"Jeffrey","family":"Campsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Trotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igal","family":"Kam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20250326","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"Diagnosis and treatment of autoimmune hepatitis.","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"R2-10-20250326","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"R3-10-20250326","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review.","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transpl"},{"key":"R4-10-20250326","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/jlts.2001.23012","article-title":"Liver transplantation using sirolimus and minimal corticosteroids (3day taper).","volume":"7","author":"Trotter","year":"2001","journal-title":"Liver Transpl"},{"key":"R5-10-20250326","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: International Autoimmune Hepatitis Group.","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"R6-10-20250326","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.510250132","article-title":"Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss.","volume":"25","author":"Stegall","year":"1997","journal-title":"Hepatology"},{"key":"R7-10-20250326","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/lt.500050514","article-title":"Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.","volume":"5","author":"Trouillot","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"R8-10-20250326","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/hep.1840040620","article-title":"Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection.","volume":"4","author":"Snover","year":"1984","journal-title":"Hepatology"},{"key":"R9-10-20250326","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00007890-199201000-00027","article-title":"Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease.","volume":"53","author":"Wright","year":"1992","journal-title":"Transplant"},{"key":"R10-10-20250326","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jlts.2002.32981","article-title":"Incidence and recurrence of autoimmunealloimmune hepatitis in liver transplant recipients.","volume":"8","author":"Molmenti","year":"2002","journal-title":"Liver Transpl"},{"key":"R11-10-20250326","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","article-title":"Recurrence of autoimmune hepatitis after liver transplantation.","volume":"68","author":"Milkiewicz","year":"1999","journal-title":"Transplantation"},{"key":"R12-10-20250326","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1016\/S0041-1345(02)03570-4","article-title":"Autoimmune hepatitis following liver transplantation: relationship to recurrent disease and steroid weaning.","volume":"34","author":"Heffron","year":"2002","journal-title":"Transplant Proc"},{"key":"R13-10-20250326","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation.","volume":"7","author":"GonzalezKoch","year":"2001","journal-title":"Liver Transpl"},{"key":"R14-10-20250326","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence.","volume":"52","author":"DuclosVallee","year":"2003","journal-title":"Gut"},{"issue":"pt 1","key":"R15-10-20250326","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jhep.2000.16666","article-title":"Liver transplantation for autoimmune hepatitis.","volume":"32","author":"Reich","year":"2000","journal-title":"Hepatology"},{"key":"R16-10-20250326","first-page":"51","article-title":"Natural history of hepatitis C and outcomes following liver transplantation.","volume":"50","author":"RodriguezLuna","year":"2004","journal-title":"Minerva Gastroenterol Dietol"},{"key":"R17-10-20250326","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplant: a time course.","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.21525","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200809000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T18:46:49Z","timestamp":1743274009000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200809000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.21525","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}